Literature DB >> 29869576

Thalamus volume change and cognitive impairment in early relapsing-remitting multiple sclerosis patients.

Juan I Rojas1, Georgina Murphy2, Francisco Sanchez1,3, Liliana Patrucco1, Maria C Fernandez2, Jimena Miguez1, Jorge Funes4, Angel Golimstok2, Edgardo Cristiano1.   

Abstract

Aims The objective of the study was to assess whether changes in the volume of the thalamus during the onset of multiple sclerosis predict cognitive impairment after accounting for the effects of brain volume loss. Methods A prospective study included patients with relapsing-remitting multiple sclerosis less than 3 years after disease onset (defined as the first demyelinating symptom), Expanded Disability Status Scale of 3 or less, no history of cognitive impairment and at least 2 years of follow-up. Patients were clinically followed up with annual brain magnetic resonance imaging and neuropsychological evaluations for 2 years. Measures of memory, information processing speed and executive function were evaluated at baseline and follow-up with a comprehensive neuropsychological test battery. After 2 years, the patients were classified into two groups, one with and the other without cognitive impairment. Brain dual-echo, high-resolution three-dimensional T1-weighted magnetic resonance imaging scans were acquired at baseline and every 12 months for 2 years. Between-group differences in thalamus volume, total and neocortical grey matter and white matter volumes were assessed using FIRST, SIENA, SIENAXr, FIRST software (logistic regression analysis P < 0.05 significant). Results Sixty-one patients, mean age 38.4 years, 35 (57%) women were included. At 2 years of follow-up, 17 (28%) had cognitive impairment. Cognitive impairment patients exhibited significantly slower information processing speed and attentional deficits compared with patients without cognitive impairment ( P < 0.001 and P = 0.02, respectively). In the cognitive impairment group a significant reduction in the percentage of thalamus volume ( P < 0.001) was observed compared with the group without cognitive impairment. Conclusion We observed a significant decrease in thalamus volume in multiple sclerosis-related cognitive impairment.

Entities:  

Keywords:  Multiple sclerosis; brain volume; cognitive impairment; thalamus

Mesh:

Year:  2018        PMID: 29869576      PMCID: PMC6111418          DOI: 10.1177/1971400918781977

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  21 in total

1.  Normalized accurate measurement of longitudinal brain change.

Authors:  S M Smith; N De Stefano; M Jenkinson; P M Matthews
Journal:  J Comput Assist Tomogr       Date:  2001 May-Jun       Impact factor: 1.826

Review 2.  Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update.

Authors:  Sibel Tekin; Jeffrey L Cummings
Journal:  J Psychosom Res       Date:  2002-08       Impact factor: 3.006

3.  Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study.

Authors:  Alvino Bisecco; Maria A Rocca; Elisabetta Pagani; Laura Mancini; Christian Enzinger; Antonio Gallo; Hugo Vrenken; Maria Laura Stromillo; Massimiliano Copetti; David L Thomas; Franz Fazekas; Gioacchino Tedeschi; Frederik Barkhof; Nicola De Stefano; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2015-04-14       Impact factor: 5.038

Review 4.  The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects.

Authors:  Alireza Minagar; Michael H Barnett; Ralph H B Benedict; Daniel Pelletier; Istvan Pirko; Mohamad Ali Sahraian; Elliott Frohman; Robert Zivadinov
Journal:  Neurology       Date:  2013-01-08       Impact factor: 9.910

5.  Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis.

Authors:  Menno M Schoonheim; Hanneke E Hulst; Roemer B Brandt; Myrte Strik; Alle Meije Wink; Bernard M J Uitdehaag; Frederik Barkhof; Jeroen J G Geurts
Journal:  Neurology       Date:  2015-01-23       Impact factor: 9.910

6.  Thalamic atrophy and cognition in multiple sclerosis.

Authors:  M K Houtchens; R H B Benedict; R Killiany; J Sharma; Z Jaisani; B Singh; B Weinstock-Guttman; C R G Guttmann; R Bakshi
Journal:  Neurology       Date:  2007-09-18       Impact factor: 9.910

7.  Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up.

Authors:  M P Amato; G Ponziani; G Pracucci; L Bracco; G Siracusa; L Amaducci
Journal:  Arch Neurol       Date:  1995-02

Review 8.  FSL.

Authors:  Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith
Journal:  Neuroimage       Date:  2011-09-16       Impact factor: 6.556

9.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

10.  Thalamic neurodegeneration in relapsing-remitting multiple sclerosis.

Authors:  M Wylezinska; A Cifelli; P Jezzard; J Palace; M Alecci; P M Matthews
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

View more
  7 in total

1.  Dose-dependent volume loss in subcortical deep grey matter structures after cranial radiotherapy.

Authors:  Steven H J Nagtegaal; Szabolcs David; Marielle E P Philippens; Tom J Snijders; Alexander Leemans; Joost J C Verhoeff
Journal:  Clin Transl Radiat Oncol       Date:  2020-11-15

Review 2.  Cognitive Dysfunction in the Early Stages of Multiple Sclerosis-How Much and How Important?

Authors:  Magdalena Oset; Mariusz Stasiolek; Mariola Matysiak
Journal:  Curr Neurol Neurosci Rep       Date:  2020-05-22       Impact factor: 5.081

3.  Morphological changes after cranial fractionated photon radiotherapy: Localized loss of white matter and grey matter volume with increasing dose.

Authors:  S H J Nagtegaal; S David; E E van Grinsven; M J E van Zandvoort; E Seravalli; T J Snijders; M E P Philippens; J J C Verhoeff
Journal:  Clin Transl Radiat Oncol       Date:  2021-08-29

4.  Brain atrophy patterns in multiple sclerosis patients treated with natalizumab and its clinical correlates.

Authors:  Arwa Rekik; Mona Aissi; Islem Rekik; Mariem Mhiri; Mahbouba Ayed Frih
Journal:  Brain Behav       Date:  2022-04-10       Impact factor: 3.405

5.  Relation of sensorimotor and cognitive cerebellum functional connectivity with brain structural damage in patients with multiple sclerosis and no disability.

Authors:  Silvia Tommasin; Viktoriia Iakovleva; Maria Assunta Rocca; Costanza Giannì; Gioacchino Tedeschi; Nicola De Stefano; Carlo Pozzilli; Massimo Filippi; Patrizia Pantano
Journal:  Eur J Neurol       Date:  2022-04-04       Impact factor: 6.288

Review 6.  Symptom Interconnectivity in Multiple Sclerosis: A Narrative Review of Potential Underlying Biological Disease Processes.

Authors:  Tanuja Chitnis; Jo Vandercappellen; Miriam King; Giampaolo Brichetto
Journal:  Neurol Ther       Date:  2022-06-09

Review 7.  Cognitive Impairment and Brain Reorganization in MS: Underlying Mechanisms and the Role of Neurorehabilitation.

Authors:  Grigorios Nasios; Christos Bakirtzis; Lambros Messinis
Journal:  Front Neurol       Date:  2020-03-06       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.